KCTD7 and progressive myoclonus epilepsy: Most homozygous and compound heterozygous mutations in the KCTD7 have been described in patients with progressive myoclonic epilepsy (PME) who have normal intracellular accumulation of storage material (Staropoli et al., 2012).